Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance

Yale University1 site in 1 country200 target enrollmentOctober 2003

ConditionsOpiate Dependence

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Opiate Dependence
Sponsor: Yale University
Enrollment: 200
Locations: 1
Primary Endpoint: Opioid free urine toxicology
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study was to expand access to buprenorphine using a mobile health care system among marginalized populations with or at high risk for HIV and observe longitudinal effects of treatment.

Registry

clinicaltrials.gov

Start Date

October 2003

End Date

September 2008

Last Updated

9 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Yale University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•At high risk for HIV (IV drug use, commercial sex worker, partner of HIV+)
•Mental Health (unmanaged or diagnosed mental illness)

Exclusion Criteria

•Benzodiazepine use
•Opiate use due to pain management issues only (present or past)

Outcomes

Primary Outcomes

Opioid free urine toxicology

Time Frame: 10/1/03-9/30/08

To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using incidence of opioid free urine toxicology.

Attendance

Time Frame: 10/1/03-9/30/08

To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using tracked attendance.

Secondary Outcomes

Access to other health care, incarceration, hospitalization acceptability of the site of care from both patient and provider perspectives, and attendance and adherence to counseling.(10/1/03-9/30/08)